TRi-1

N/A

Report date: 2023/03/21 13:49:50
NME

Base Information

Drug NameTRi-1
Drug Alias NameTRi-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThioredoxin reductase 1 inhibitors
TargetsThioredoxin reductase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKarolinska Institutet
China Registration ClassN/A

Develop Information

Active CompaniesKarolinska Institutet
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A